Paul Andrew BARSANTI,Matthew T. BURGER,Yan LOU,Gisele A. NISHIGUCHI,Valery Rostislavovich POLYAKOV,Savithri RAMURTHY,Sharadha SUBRAMANIAN,Benjamin R. TAFT,Huw Rowland TANNER,Lifeng WAN
申请号：
US15510613
公开号：
US20170260200A1
申请日:
2015.09.11
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides compounds of Formula (I) and (II) as described herein, and salts thereof and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.
